In summary, non‐mutant and mutant CCNF expression in CNS neurons of mice is sufficient to reproduce aspects of the clinical presentation of ALS, including functional deficits and TDP‐43 neuropathology, making it a good candidate for developing and testing tailored therapies for ALS. The gene discussed is TARDBP; the disease is amyotrophic lateral sclerosis.